You can:
Name | Beta-3 adrenergic receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | ADRB3 |
Synonym | ADRB Adrb-3 adrenergic receptor atypical beta-adrenoceptor beta 3-AR [ Show all ] |
Disease | Urinary incontinence Diabetes Glaucoma Hypertension Irritable bowel syndrome [ Show all ] |
Length | 408 |
Amino acid sequence | MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS |
UniProt | P13945 |
Protein Data Bank | N/A |
GPCR-HGmod model | P13945 |
3D structure model | This predicted structure model is from GPCR-EXP P13945. |
BioLiP | N/A |
Therapeutic Target Database | T51408 |
ChEMBL | CHEMBL246 |
IUPHAR | 30 |
DrugBank | BE0001012, BE0004872 |
Name | UNII-42FZ27IZLV |
---|---|
Molecular formula | C19H22ClNO4 |
IUPAC name | 2-[4-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]phenoxy]acetic acid |
Molecular weight | 363.838 |
Hydrogen bond acceptor | 5 |
Hydrogen bond donor | 3 |
XlogP | 0.9 |
Synonyms | (R*, R*) (4-{2-[2-(3-Chloro-phenyl)-2-hydroxy-ethylamino]-propyl}-phenoxy)-acetic acid Acetic acid, (4-((2R)-2-(((2R)-2-(3-chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)- BRL37344 SCHEMBL304308 2-(4-((R)-2-((R)-2-(3-chlorophenyl)-2-hydroxyethylamino)propyl)phenoxy)acetic acid [ Show all ] |
Inchi Key | ZGGNJJJYUVRADP-ACJLOTCBSA-N |
Inchi ID | InChI=1S/C19H22ClNO4/c1-13(21-11-18(22)15-3-2-4-16(20)10-15)9-14-5-7-17(8-6-14)25-12-19(23)24/h2-8,10,13,18,21-22H,9,11-12H2,1H3,(H,23,24)/t13-,18+/m1/s1 |
PubChem CID | 9841972 |
ChEMBL | CHEMBL284782 |
IUPHAR | 567 |
BindingDB | 50002133 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
Activation | 23.0 % | PMID9873681 | ChEMBL |
Activity | 0.67 - | Bioorg. Med. Chem. Lett., (1997) 7:12:1583 | ChEMBL |
Activity | 23.0 % | PMID21170122 | ChEMBL |
EC50 | 0.095 nM | PMID12657269 | BindingDB |
EC50 | 0.095 nM | PMID12657269 | ChEMBL |
EC50 | 1.1 nM | PMID18083578 | BindingDB,ChEMBL |
EC50 | 2.188 nM | PMID12502364 | ChEMBL |
EC50 | 2.2 nM | PMID12502364 | BindingDB,ChEMBL |
EC50 | 5.9 nM | PMID18083578 | BindingDB,ChEMBL |
EC50 | 21.0 nM | PMID12657269, PMID21170122 | BindingDB,ChEMBL |
EC50 | 450.0 nM | PMID9873681 | BindingDB,ChEMBL |
EC50 | 680.0 nM | Bioorg. Med. Chem. Lett., (1997) 7:12:1583, , Bioorg. Med. Chem. Lett., (1996) 6:19:2253 | BindingDB,ChEMBL |
IA | 0.67 - | Bioorg. Med. Chem. Lett., (1996) 6:19:2253 | ChEMBL |
Intrinsic activity | 67.0 % | PMID11714605 | ChEMBL |
Intrinsic activity | 76.0 % | PMID18083578 | ChEMBL |
Intrinsic activity | 95.0 % | PMID12657269 | ChEMBL |
Intrinsic activity | 109.0 % | PMID12657269 | ChEMBL |
Ki | 100.0 - 398.0 nM | PMID8719421, PMID7903415, PMID7912272, PMID14730417 | IUPHAR |
Ki | 660.0 nM | PMID11714605 | BindingDB,ChEMBL |
Ki | 960.0 nM | , Bioorg. Med. Chem. Lett., (1997) 7:12:1583, Bioorg. Med. Chem. Lett., (1996) 6:19:2253 | BindingDB,ChEMBL |
zhanglabzhanggroup.org | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218